Kymera Therapeutics, Inc. (KYMR)
82.98
+4.75
(+6.07%)
USD |
NASDAQ |
Jun 11, 15:17
Kymera Therapeutics Max Drawdown (5Y) : 87.51% for May 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| May 31, 2026 | 87.51% |
| April 30, 2026 | 87.51% |
| March 31, 2026 | 87.51% |
| February 28, 2026 | 87.51% |
| January 31, 2026 | 87.51% |
| December 31, 2025 | 87.51% |
| November 30, 2025 | 87.51% |
| October 31, 2025 | 87.51% |
| September 30, 2025 | 87.51% |
| August 31, 2025 | 87.51% |
| July 31, 2025 | 87.51% |
| June 30, 2025 | 87.51% |
| May 31, 2025 | 87.51% |
| April 30, 2025 | 87.51% |
| March 31, 2025 | 87.51% |
| February 28, 2025 | 87.51% |
| January 31, 2025 | 87.51% |
| December 31, 2024 | 87.51% |
| November 30, 2024 | 87.51% |
| October 31, 2024 | 87.51% |
| September 30, 2024 | 87.51% |
| August 31, 2024 | 87.51% |
| July 31, 2024 | 87.51% |
| June 30, 2024 | 87.51% |
| May 31, 2024 | 87.51% |
| Date | Value |
|---|---|
| April 30, 2024 | 87.51% |
| March 31, 2024 | 87.51% |
| February 29, 2024 | 87.51% |
| January 31, 2024 | 87.51% |
| December 31, 2023 | 87.51% |
| November 30, 2023 | 87.51% |
| October 31, 2023 | 87.51% |
| September 30, 2023 | 84.17% |
| August 31, 2023 | 83.91% |
| July 31, 2023 | 83.91% |
| June 30, 2023 | 83.91% |
| May 31, 2023 | 83.91% |
| April 30, 2023 | 83.91% |
| March 31, 2023 | 83.91% |
| February 28, 2023 | 83.91% |
| January 31, 2023 | 83.91% |
| December 31, 2022 | 83.91% |
| November 30, 2022 | 83.91% |
| October 31, 2022 | 83.91% |
| September 30, 2022 | 83.91% |
| August 31, 2022 | 83.91% |
| July 31, 2022 | 83.91% |
| June 30, 2022 | 83.91% |
| May 31, 2022 | 83.86% |
| April 30, 2022 | 64.61% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Revolution Medicines, Inc. | 73.29% |
| Erasca, Inc. | -- |
| Arrowhead Pharmaceuticals, Inc. | 88.96% |
| Sarepta Therapeutics, Inc. | 93.33% |
| Vir Biotechnology, Inc. | 94.85% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -13.88 |
| Beta (5Y) | 2.020 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 77.24% |
| Historical Sharpe Ratio (5Y) | 0.0981 |
| Historical Sortino (5Y) | 0.1945 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 27.26% |